Jäger W - Search Results

1

Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.

Fehm T, Maul H, Gebauer S, Scharf A, Baier P, Sohn C, Jäger W, Gebauer G. Fehm T, et al. Among authors: jager w. Strahlenther Onkol. 2005 Sep;181(9):580-6. doi: 10.1007/s00066-005-1374-y. Strahlenther Onkol. 2005. PMID: 16170485

2

Clinical utility of serial serum c-erbB-2 determinations in the follow-up of breast cancer patients.

Fehm T, Gebauer G, Jäger W. Fehm T, et al. Among authors: jager w. Breast Cancer Res Treat. 2002 Sep;75(2):97-106. doi: 10.1023/a:1019601022456. Breast Cancer Res Treat. 2002. PMID: 12243512

3

Prognostic significance of serum HER2 and CA 15-3 at the time of diagnosis of metastatic breast cancer.

Fehm T, Jäger W, Krämer S, Sohn C, Solomayer E, Wallwiener D, Gebauer G. Fehm T, et al. Among authors: jager w. Anticancer Res. 2004 May-Jun;24(3b):1987-92. Anticancer Res. 2004. PMID: 15274389 Free article.

4

Changes of serum HER2 status during clinical course of metastatic breast cancer patients.

Fehm T, Jäger W, Kraemer S, Sohn C, Solomayer-Meyberg G, Solomayer EF, Kurek R, Wallwiener D, Gebauer G. Fehm T, et al. Among authors: jager w. Anticancer Res. 2004 Nov-Dec;24(6):4205-10. Anticancer Res. 2004. PMID: 15739264 Free article.

5

Tumor size, axillary lymph node status and steroid receptor expression in breast cancer: prognostic relevance 5 years after surgery.

Gebauer G, Fehm T, Lang N, Jäger W. Gebauer G, et al. Among authors: jager w. Breast Cancer Res Treat. 2002 Sep;75(2):167-73. doi: 10.1023/a:1019601928290. Breast Cancer Res Treat. 2002. PMID: 12243509

6

Evaluation of CA125, physical and radiological findings in follow-up of ovarian cancer patients.

Fehm T, Heller F, Krämer S, Jäger W, Gebauer G. Fehm T, et al. Among authors: jager w. Anticancer Res. 2005 May-Jun;25(3A):1551-4. Anticancer Res. 2005. PMID: 16033059 Free article.

7

The prognostic significance of c-erbB-2 serum protein in metastatic breast cancer.

Fehm T, Maimonis P, Katalinic A, Jäger WH. Fehm T, et al. Among authors: jager wh. Oncology. 1998 Jan-Feb;55(1):33-8. doi: 10.1159/000011832. Oncology. 1998. PMID: 9428373

8

Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients.

Fehm T, Maimonis P, Weitz S, Teramoto Y, Katalinic A, Jäger W. Fehm T, et al. Among authors: jager w. Breast Cancer Res Treat. 1997 Mar;43(1):87-95. doi: 10.1023/a:1005700812422. Breast Cancer Res Treat. 1997. PMID: 9065602

9

mRNA expression of components of the insulin-like growth factor system in breast cancer cell lines, tissues, and metastatic breast cancer cells.

Gebauer G, Jäger W, Lang N. Gebauer G, et al. Among authors: jager w. Anticancer Res. 1998 Mar-Apr;18(2A):1191-5. Anticancer Res. 1998. PMID: 9615787

10

Cytotoxic effect of conjugates of doxorubicin and human chorionic gonadotropin (hCG) in breast cancer cells.

Gebauer G, Fehm T, Beck EP, Berkholz A, Licht P, Jäger W. Gebauer G, et al. Among authors: jager w. Breast Cancer Res Treat. 2003 Jan;77(2):125-31. doi: 10.1023/a:1021301001208. Breast Cancer Res Treat. 2003. PMID: 12602911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters